ROCHESTER, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) — OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a number one supplier of point-of-care expertise options serving to sufferers begin and keep on remedy, right now introduced the third annual Innovate4Outcomes® occasion co-sponsored by Melinta Therapeutics. This digital occasion will happen on December 1, 2022. The sponsors are inviting participation from healthcare suppliers, pharmaceutical and medical expertise producers, healthcare advertising and marketing and promoting companies, and others within the life sciences {industry}.
Innovate4Outcomes is a design-thinking, half-day occasion that brings collectively these thinking about cross-industry collaboration to brainstorm potential pathways to scale back the specter of systemic healthcare challenges within the US. This yr’s problem has been recognized by the World Health Organization as one of many ten most urgent present world well being challenges: Antimicrobial Resistance (AMR). AMR has many sides that are aggravated by siloed care supply pathways and social points, amongst them remedy resistance, challenges in growing new therapies, supplier training and well being fairness. A current examine printed in The Lancet estimated that there have been roughly 5 million world deaths related to bacterial AMR in 2019, along with quite a few different dangerous impacts on human well being and longevity.
“We’re delighted to co-sponsor this event with OptimizeRx,” mentioned Matthew Balogh, Head of Digital Marketing, Melinta Therapeutics. “AMR is a far-reaching health concern that will require new thinking to address, and Innnovate4Outcomes allows the healthcare community to come together and leverage their own varied backgrounds and experiences to add to the conversation.”
On the day of the occasion, registrants will probably be divided into groups and will be taught which of three systemic healthcare challenges associated to AMR they are going to be assigned. Six groups, two for every problem, will work collectively to ascertain future approaches to this important well being concern. Teams will then pitch their concepts to a panel of judges, and OptimizeRx will spend money on the successful idea with the purpose of making a business case for additional growth.
“Our annual design-thinking in healthcare event, Innovate4Outcomes, speaks to the visionary approach we take every day in working with our industry colleagues to improve therapy awareness, access, and adherence for patients,” mentioned Maria Cipicchio, SVP of Marketing and Communications, OptimizeRx. “Global health challenges like AMR take creative approaches to problem-solving, and we hold this annual event to envision a better future state of healthcare. We’re delighted to be in a position this year to allow the opportunity to extend ongoing support to investigate whether we can bring the winning idea to life.”
The occasion is free, and invites are required for occasion entry. Visit this hyperlink to request an invite.
About OptimizeRx
OptimizeRx supplies best-in-class well being expertise that permits care-focused engagement between life sciences organizations, healthcare suppliers, and sufferers at crucial junctures all through the affected person care journey. Connecting over 60% of U.S. healthcare suppliers and thousands and thousands of their sufferers by way of probably the most clever expertise platform embedded inside a proprietary digital point-of-care community, OptimizeRx helps sufferers begin and keep on their drugs.
For extra info, comply with the Company on Twitter, LinkedIn, or go to www.optimizerx.com.
About Melinta Therapeutics
Melinta Therapeutics, LLC supplies revolutionary therapies to individuals impacted by acute and life-threatening sicknesses. Our portfolio presently consists of six commercial-stage merchandise: Baxdela® (delafloxacin), Kimyrsa® (oritavancin), Minocin® (minocycline) for Injection, Orbactiv® (oritavancin), TOPROL-XL® (metoprolol succinate) and Vabomere® (meropenem and vaborbactam). With an unsurpassed dedication to suppliers and the sufferers they serve, we work to make sure that all individuals who want our therapies can obtain them. We focus our increasing portfolio on serving sufferers with an unmet want as a result of that’s how we take advantage of significant affect. At Melinta, we’re visionaries devoted to innovation whereas staying grounded in what issues most: sufferers. For further info, together with product and respective vital security info, please go to our web site.
Important Cautions Regarding Forward Looking Statements
This press launch incorporates forward-looking statements inside the which means of the Private Securities Litigation Reform Act of 1995. Words akin to “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or different comparable phrases and expressions are supposed to establish these forward-looking statements. All statements that replicate the Company’s expectations, assumptions, projections, beliefs or opinions concerning the future, aside from statements of historic reality, are forward-looking statements, together with, with out limitation, statements referring to the Company’s progress, business plans and future efficiency. These forward-looking statements are based mostly on the Company’s present expectations and assumptions concerning the Company’s business, the economy, and different future situations. The Company disclaims any intention or obligation to publicly replace or revise any forward-looking statements, whether or not due to new info, future occasions, or in any other case, besides as required by relevant legislation. Forward-looking statements are inherently topic to dangers and uncertainties, a few of which can’t be predicted, or quantified. Future occasions and precise outcomes might differ materially from these set forth in, contemplated by, or underlying the forward-looking statements. The dangers and uncertainties to which forward-looking statements are topic embody, however should not restricted to, the impact of presidency regulation, competitors, and different dangers summarized within the Company’s Annual Report on Form 10-Okay for the fiscal yr ended December 31, 2021, its subsequent Quarterly Reports on Form 10-Q, and its different filings with the Securities and Exchange Commission.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
[email protected]
Media Relations Contact
Kimberley Sirk, Media Relations Manager
[email protected]
Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
[email protected]
